Page last updated: 2024-11-02

benoxinate and Sicca Syndrome

benoxinate has been researched along with Sicca Syndrome in 1 studies

benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.

Research Excerpts

ExcerptRelevanceReference
" While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare."5.39Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome. ( Ansari, H; Spencer, N; Weinberg, L, 2013)
" While corneal complications following long-term use or misuse of local anaesthetic solutions have been described, toxic epitheliopathy after a single application of six drops of preservative free oxybuprocaine is rare."1.39Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome. ( Ansari, H; Spencer, N; Weinberg, L, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ansari, H1
Weinberg, L1
Spencer, N1

Other Studies

1 other study available for benoxinate and Sicca Syndrome

ArticleYear
Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome.
    BMJ case reports, 2013, Sep-13, Volume: 2013

    Topics: Administration, Ophthalmic; Aged; Anesthetics, Local; Cataract Extraction; Corneal Diseases; Epithel

2013